Coherus Oncology annual meeting results: all director nominees elected, say-on-pay and ESPP amendment approved

Coherus Oncology, Inc.

Stockholders elected Jill O'Donnell-Tormey, Michael Ryan, and Ali J. Satvat as Class II directors with 32.8M, 32.7M, and 27.8M votes for, respectively.
Ratified Ernst & Young as independent auditor for FY 2025 with 74.5M votes for, 777K against, 306K abstain.
Advisory say-on-pay resolution approved with 19.2M for, 16.2M against, 3.6M abstain; broker non-votes 36.7M.
Amendment to 2014 Employee Stock Purchase Plan approved with 27.7M for, 7.6M against, 3.6M abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.